etoposide has been researched along with Gastrinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faiss, S; Raue, F; Schaaf, L; ScherĂ¼bl, H; Zeitz, M | 1 |
Kim, DM; Lee, S; Lim, SK; Park, SY; Park, YN; Rhee, Y; Song, SY; Youn, JC | 1 |
2 other study(ies) available for etoposide and Gastrinoma
Article | Year |
---|---|
[Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
Topics: Anti-Ulcer Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Gastrinoma; Gastrointestinal Agents; Humans; Insulinoma; Interferon-alpha; Multiple Endocrine Neoplasia Type 1; Neoplasm Metastasis; Octreotide; Omeprazole; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Somatostatin; Streptozocin; Time Factors; Zollinger-Ellison Syndrome | 2004 |
Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Combined Chemotherapy Protocols; Corticotropin-Releasing Hormone; Cushing Syndrome; Duodenal Neoplasms; Etoposide; Female; Gastrinoma; Humans; Hydrocortisone; Liver Neoplasms; Paclitaxel; Pancreatic Neoplasms | 2007 |